Role of Soluble ST2 as a Marker for Rejection after Heart Transplant
نویسندگان
چکیده
منابع مشابه
Role of Soluble ST2 as a Marker for Rejection after Heart Transplant
BACKGROUND AND OBJECTIVES Endomyocardial biopsy is obligatory during the first year after heart transplant (HTx) for the surveillance of acute rejection. Previous attempts using cardiac biomarkers for the detection of rejection failed to show enough evidence to substitute endomyocardial biopsy. Therefore, this study sought the possibility of using soluble ST2 (sST2), a novel cardiovascular mark...
متن کاملSerum soluble ST2 as a biochemical marker of acute heart failure: future areas of research.
he investigation into biochemical markers is modifying the pproach to the diagnosis and management of heart failure HF). Over the last decade, natriuretic peptides (NPs) have een shown to be particularly useful in confirming or efuting the diagnosis of HF as well as stratifying long-term isk profiles. Several novel cardiac, metabolic, and inflamatory biochemical markers have emerged in the fiel...
متن کاملRole of Soluble ST2 as a Prognostic Marker in Patients with Acute Heart Failure and Renal Insufficiency
This study sought to assess the relationship between serum concentrations of the soluble ST2 (sST2) and B-type natriuretic peptide (BNP) and investigate the role of sST2 as a prognosticator in patients hospitalized with acute heart failure (HF) and renal insufficiency. sST2 was measured at admission and discharge in 66 patients hospitalized with acute decompensated HF and renal insufficiency (e...
متن کاملSoluble ST2: A Novel Prognostic Biomarker of Heart Failure.
Previous studies have demonstrated the role of ST2 in predicting hospitalization and mortality in heart failure, independent of natriuretic peptides and other clinical variables. 9-17 In 2011, the U.S. Food and Drug Administration (FDA) delared the Presage ST2 Assay (Critical Diagnostics, San Diego, California, USA), which is typically used in conjunction with clinical evaluation as an aid in a...
متن کاملMicroRNAs as non-invasive biomarkers of heart transplant rejection.
AIM Rejection is one of the major causes of late cardiac allograft failure and at present can only be diagnosed by invasive endomyocardial biopsies. We sought to determine whether microRNA profiling could serve as a non-invasive biomarker of cardiac allograft rejection. METHODS We included 113 heart transplant recipients from four referral French institutions (test cohort, n = 60, validation ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Korean Circulation Journal
سال: 2016
ISSN: 1738-5520,1738-5555
DOI: 10.4070/kcj.2016.46.6.811